Log In Sign up
The largest database of trusted experimental protocols

Crt0066854

Manufactured by Bio-Techne
Visit Supplier

CRT0066854 is a laboratory equipment product from Bio-Techne. This product serves as a core functional component, but a detailed description while maintaining an unbiased and factual approach is not available.

Automatically generated - may contain errors

Lab products found in correlation

Saracatinib, by Selleck Chemicals (2 mentions) Dasatinib, by Selleck Chemicals (2 mentions) Erlotinib, by Selleck Chemicals (2 mentions) Auranofin, by Santa Cruz Biotechnology (2 mentions)

2 protocols using crt0066854

1

Cell Viability Assay with Kinase Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
5000 cells/well were plated in 96-well plates and allowed to attach for 48 hours. Cells were treated with auranofin (Santa Cruz Biotechnology, cat# SC202476A), CRT0066854 (Tocris, cat# 5922), saracatinib (Selleck Chemicals, cat# S1006), dasatinib (Selleck Chemicals, cat# S1021), or erlotinib (Selleck Chemicals, cat# S7786) for 72 hours. Cell viability was determined using CellTiter-Glo and results normalized to cells treated with vehicle.
Kenchappa R.S., Liu Y., Argenziano M.G., Banu M.A., Mladek A.C., West R., Luu A., Quiñones-Hinojosa A., Hambardzumyan D., Justilien V., Leitges M., Sarkaria J.N., Sims P.A., Canoll P., Murray N.R., Fields A.P, & Rosenfeld S.S. (2021). Protein kinase Cι and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities. Cell reports, 37(8), 110054.
+ Open protocol
+ Expand
2

Cell Viability Assay with Kinase Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
5000 cells/well were plated in 96-well plates and allowed to attach for 48 hours. Cells were treated with auranofin (Santa Cruz Biotechnology, cat# SC202476A), CRT0066854 (Tocris, cat# 5922), saracatinib (Selleck Chemicals, cat# S1006), dasatinib (Selleck Chemicals, cat# S1021), or erlotinib (Selleck Chemicals, cat# S7786) for 72 hours. Cell viability was determined using CellTiter-Glo and results normalized to cells treated with vehicle.
Kenchappa R.S., Liu Y., Argenziano M.G., Banu M.A., Mladek A.C., West R., Luu A., Quiñones-Hinojosa A., Hambardzumyan D., Justilien V., Leitges M., Sarkaria J.N., Sims P.A., Canoll P., Murray N.R., Fields A.P, & Rosenfeld S.S. (2021). Protein kinase Cι and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities. Cell reports, 37(8), 110054.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!